Replimune Group (NASDAQ: REPL)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Replimune Group (NASDAQ: REPL) through any online brokerage.
The latest price target for Replimune Group (NASDAQ: REPL) was reported by Wedbush on Tuesday, May 24, 2022. The analyst firm set a price target for 52.00 expecting REPL to rise to within 12 months (a possible 182.92% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Replimune Group (NASDAQ: REPL) is $18.38 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Replimune Group.
Replimune Group’s Q1 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Replimune Group.
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.